Why the study?
Does eplerenone prevent podocyte damage and glomerulosclerosis in Dahl salt-hypertensive rats?
Population
Four-week-old Dahl salt-resistant and salt-sensitive rats fed a 0.3% or 8.0% NaCl diet
Comparison
Eplerenone or hydralazine for 6 weeks vs Untreated salt-loaded Dahl salt-sensitive rats
Design
Preclinical
Follow-up
6 weeks
Authors
Loading...
Eplerenone may confer podocyte protection beyond BP reduction in salt-sensitive hypertension; hypothesis-generating and requires clinical validation before practice change.
Does eplerenone prevent podocyte damage and glomerulosclerosis in Dahl salt-hypertensive rats?
Inhibition of aldosterone by eplerenone protects against podocyte damage, proteinuria, and glomerulosclerosis in a salt-sensitive hypertensive rat model, independent of blood pressure reduction.
Nagase et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: